ITIH4 anticorps (AA 885-917)

N° du produit ABIN5533543

Détail du produit anti-ITIH4 anticorps

Antigène: ITIH4 (Inter alpha Globulin Inhibitor H4 (ITIH4))

Épitope: AA 885-917

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ITIH4 est non-conjugé

Application: Western Blotting (WB), Flow Cytometry (FACS)

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This ITIH4 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 885-917 amino acids from human ITIH4.

Isotype: Ig Fraction

Information d'application

Indications d'application: For FACS starting dilution is: 1:25

For WB starting dilution is: 1:2000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: Supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Détails sur ITIH4

Antigène: ITIH4 (Inter alpha Globulin Inhibitor H4 (ITIH4))

Autre désignation: ITIH4 (ITIH4 Produits)

Synonymes: anticorps ITI-HC4, anticorps Itih-4, anticorps GP120, anticorps H4P, anticorps IHRP, anticorps ITIHL1, anticorps PK-120, anticorps PK120, anticorps inter alpha-trypsin inhibitor, heavy chain 4, anticorps inter-alpha-trypsin inhibitor heavy chain family member 4, anticorps inter-alpha-trypsin inhibitor heavy chain family, member 4, anticorps Itih4, anticorps ITIH4

Sujet: Type II acute-phase protein (APP) involved in inflammatory responses to trauma. May also play a role in liver development or regeneration.

Poids moléculaire: 103 kDa

ID gène: 3700

UniProt: Q14624

Pathways: Glycosaminoglycan Metabolic Process